Interview with Dr. Raman Muthusamy: Barrett's Conundrum
Speaking with Dr. Raman Muthusamy (Clinical Professor of Medicine, UCLA) on the challenge of risk-stratifying Barrett's esophagus patients so we can focus our effective treatments on high-risk patients and avoid overtreatment of low-risk patients.
Interview with Dr. Sri Komanduri, re: the 2022 AGA Clinical Practice Update
Castle Biosciences sat down with Dr. Sri Komanduri, Associate Chief of Gastroenterology and Hepatology at Northwestern Medicine, to discuss the American Gastroenterological Association (AGA) Clinical Practice Update, published July 01, 2022.
Molecular Prognostic Tests are Changing Management of Dermatologic Cancers
Learn more about how Gene Expression Profiling (GEP) can be used to individualize patient care and management of melanoma.
More Accurately Predicting Individual Risk of Recurrence or Metastasis
DecisionDx- Melanoma can be used to determine what level of follow-up, imaging, and referrals are appropriate for individual patients.
Mary D. – Taking Matters Into Her Own Hands
Mary sat in disbelief. How could that small dot in her eye, the one her doctor had called a “freckle” just twelve years ago, now be a malignant tumor?
Peter L. – The Test of Time
It was just two days before the radiation treatment of his uveal melanoma, or eye cancer.
Jerry W. – A Second Chance for Jerry
He just knew he was going to die. In September 2009, Jerry W., a retired GM employee, was diagnosed with uveal melanoma. His entire world collapsed.
Mary F. – Marking “Cancerversaries”
Since her diagnosis with uveal melanoma in September 2013, life looks very different for Mary Judy French.